Macrophage polarization in interstitial lung diseases

P. Wojtan, M. Mierzejewski, I. Osinska, J. Domagala-Kulawik (Warsaw, Poland)

Source: International Congress 2014 – ILDs 2
Session: ILDs 2
Session type: Thematic Poster Session
Number: 756
Disease area: Interstitial lung diseases

Congress or journal article abstractE-poster

Rating: 0
You must login to grade this presentation.

Share or cite this content

Citations should be made in the following way:
P. Wojtan, M. Mierzejewski, I. Osinska, J. Domagala-Kulawik (Warsaw, Poland). Macrophage polarization in interstitial lung diseases. Eur Respir J 2014; 44: Suppl. 58, 756

You must login to share this Presentation/Article on Twitter, Facebook, LinkedIn or by email.

Member's Comments

No comment yet.
You must Login to comment this presentation.


Related content which might interest you:
Autophagy is not impaired in BALF alveolar macrophages in IPF: Preliminary results
Source: International Congress 2014 – ILDs 3
Year: 2014

Cytokine expression profiles of lymphocytes from bronchoalveolar lavage fluid and blood in patients with interstitial lung diseases(ILDs)
Source: International Congress 2014 – ILDs 5
Year: 2014

Feroptosis of alveolar macrophages in lung cancer
Source: International Congress 2016 – Lung cancer and immune cells: friends or foes?
Year: 2016


Relation of cytokine expression profile of T-cells from blood and bronchoalveolar lavage fluid with HRCT pattern in fibrosing interstitial lung diseases
Source: International Congress 2014 – ILDs 3
Year: 2014

Titel: MicroRNA analysis in Epithelial Lining Fluid (ELF) compared to Bronchoalveolar Lavage (BAL) in Interstitial pulmonary fibrosis (IPF)
Source: International Congress 2014 – IPF and surroundings
Year: 2014

Cytologicalfeaturesof bronchoalveolar lavage in different variants of exogenous allergic alveolitis
Source: International Congress 2014 – ILDs 5
Year: 2014


Usefulness of bronchoalveolar lavage in the diagnosis of desquamative interstitial pneumonia
Source: International Congress 2014 – ILDs 2
Year: 2014

Multiple segmental lavage in the treatment of pulmonary alveolar proteinosis
Source: International Congress 2014 – ILDs 6
Year: 2014


Profile of airway mucins in bronchoalveolar lavage fluid of patients with pulmonary alveolar proteinosis
Source: International Congress 2015 – Systemic and airway biomarkers
Year: 2015

Investigation of mitochondria homeostasis and mitophagy in bronchoalveolar lavage fluid (BALF) cells in pulmonary fibrosis
Source: International Congress 2015 – IPF pathogenesis
Year: 2015


Phenotypes of alveolar macrophages in normal human lung and their polarization with disease
Source: International Congress 2014 – New insights into monocyte and macrophage biology
Year: 2014

The impact of age on bronchoalveolar lavage (BAL) cytoimmunological pattern in interstitial lung diseases (ILD) and in healthy controls
Source: International Congress 2014 – ILDs 4
Year: 2014

Expression phenotypes of CD4+ and CD8+ T lymphocytes in bronchoalveolar lavage fluid and blood in lung fibrosis
Source: International Congress 2014 – ILDs 2
Year: 2014

Screening potential biomarkers for idiopathic pulmonary fibrosis in bronchoalveolar lavage fluid
Source: International Congress 2014 – ILDs 1
Year: 2014


Pulmonary alveolar proteinosis – Gender differences in a 20 cases analysis in a reference institute in Romania
Source: International Congress 2014 – ILDs 3
Year: 2014

Change of A549 cells characteristics upon stimulation with BALF of patients with interstitial lung diseases
Source: International Congress 2014 – ILDs 4
Year: 2014


Mucus production, lung inflammation and functional decay in IPF
Source: International Congress 2014 – ILDs: pathogenesis and clinical features
Year: 2014

Lung cancer immune cells exhibit inhibited inflammasome response
Source: International Congress 2015 – Biomarkers, immunology and molecular pathology of lung cancer
Year: 2015

Eosinophilic lung disease
Source: International Congress 2016 – Orphan diseases I
Year: 2016


Bronchoalveolar lavage cytokine profile in patients with Pulmonary Langerhans Cell Histiocytosis differs from other interstitial lung diseases
Source: Virtual Congress 2020 – Possible scenarios in the challenging future of rare diffuse parenchymal lung diseases
Year: 2020